BRNSNasdaq United Kingdom
Market cap
$24.468 M
$0.60 +6.02%
Close of 7 Aug 2026
Revenue
$0.00
#3658 by revenue
Earnings
-$66.4M
Loss-making
Shares outstanding
40,848,893
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Barinthus Biotherapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.